openPR Logo
Press release

Renal Biomarker Market Presume to Groe at 7.0% CAGR During 2016-2026

10-27-2017 01:05 PM CET | Health & Medicine

Press release from: Future Market Insights

Renal Biomarker Market Presume to Groe at 7.0% CAGR During

Future Market Insights delivers key insights on the global renal biomarker market in a new report titled “Renal Biomarker Market: Global Industry Analysis and Opportunity Assessment, 2016–2026.” In terms of revenue, the global renal biomarker market is projected to register a healthy CAGR of 7.0% over the forecast period. In this report, Future Market Insights throws light on the various factors and trends impacting market growth over the forecast period (2016 – 2026).

View Full Report TOC, Figures and Tables @ https://www.futuremarketinsights.com/reports/renal-biomarker-market

Segmentation highlights

The global renal biomarker market is segmented on the basis of Biomarker Type (Functional Biomarker, Up-Regulated Proteins, Others); Diagnostic Technique (Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay, Liquid Chromatography-Mass Spectrometry); and End User (Diagnostic Labs,Outpatient Clinics, Research Centres, Hospitals).

Need more information about Report methodology ? https://www.futuremarketinsights.com/askus/rep-gb-1731

The Functional Biomarker type segment is anticipated to be valued at US$ 471.2 Mn by the end of 2016, registering a CAGR of 7.6% over the forecast period. The Up-Regulated Proteins type segment is estimated to create absolute $ opportunity of US$ 19.5 Mn in 2017 over 2016
The Enzyme Linked Immunosorbent Assay diagnostic technique segment is anticipated to witness high Y-o-Y rates of growth throughout the forecast period and is anticipated to reach a market valuation of US$ 390.9 Mn by the end of 2016. The Particle-Enhanced Turbidimetric Immunoassay diagnostic technique segment is estimated to register a CAGR of 7.0% over the forecast period
The Diagnostic Labs end user segment is anticipated to reach a market value share of US$ 308.4 Mn by the end of 2016. The Outpatient Clinics end user segment is estimated to hold a market value share of 30.1% by the end of 2016, making it the second highest end user growth segment of the global renal biomarker market

Request and Download Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1731

Regional analysis

The global renal biomarker market is segmented into the seven key regions of North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan, and Middle East & Africa (MEA). The North America renal biomarker market is projected to witness high Yea-on-Year growth throughout the forecast period. The market in this region is anticipated to witness a CAGR of 7.6% over the forecast period. The presence of leading renal biomarker manufacturers and established distribution channels in North America is expected to create significant growth opportunities over the next 10 years. The Western Europe renal biomarker market is estimated to represent absolute $ opportunity of US$ 14.1 Mn in 2017 over 2016.

Vendor insights

The global renal biomarker market report profiles a few of the top companies dominating the global market. Leading market players featured in the report include Thermo Fisher Scientific Inc., BIOPORTO A/S, Abbott Laboratories, Astute Medical, Inc., Randox Laboratories Ltd. and Beckman Coulter, Inc. (Danaher Corporation). The report discusses individual strategies adopted by these companies in terms of enhancing product designing, creating new manufacturing facilities, market consolidation, and advanced R&D initiatives.

Buy Full Renal Biomarker Market Report@ https://www.futuremarketinsights.com/checkout/1731

About Us –
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.

CONTACT:
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Renal Biomarker Market Presume to Groe at 7.0% CAGR During 2016-2026 here

News-ID: 790262 • Views:

More Releases from Future Market Insights

Electronic Tongue Market will grow USD 774.2 million by 2035, at a 4.5% CAGR, fueled by demand for smart diagnostics and medical R&D.
Electronic Tongue Market will grow USD 774.2 million by 2035, at a 4.5% CAGR, fu …
The global electronic tongue market is advancing rapidly, poised to reach USD 497.9 million in 2025 and climb to USD 774.2 million by 2035, growing at a promising 4.5% CAGR. The increasing demand for precision diagnostics, pharmaceutical quality control, and personalized medicine is driving this technological surge, positioning the electronic tongue as a futuristic, non-invasive diagnostic instrument in healthcare and pharmaceuticals. Electronic tongues, by design, mimic human sensory functions through an
ESD Tapes and Labels market will expand USD 4,253.3 million by 2035, growing at 4.5% CAGR with strong electronics and aerospace demand.
ESD Tapes and Labels market will expand USD 4,253.3 million by 2035, growing at …
The global market for ESD (electrostatic discharge) tapes and labels is entering a new decade of expansion driven by technological innovation, the rise of miniaturized electronics, and heightened quality standards in manufacturing. Valued at USD 2,738.8 million in 2025, the market is expected to reach USD 4,253.3 million by 2035, expanding at a steady 4.5% CAGR. This reflects a world increasingly dependent on efficient anti-static solutions that ensure the protection
Catalase Market will rise USD 575.9 million by 2035 at 3.1% CAGR, driven by sustainable innovations and expanding applications.
Catalase Market will rise USD 575.9 million by 2035 at 3.1% CAGR, driven by sust …
The global market for catalase is preparing for steady long-term expansion, driven by green chemistry, renewable sourcing, and biotechnology-driven production upgrades. Projected to reach USD 424.5 million in 2025 and USD 575.9 million by 2035, the industry's 3.1% CAGR reflects its broadening influence across critical sectors including food and beverages, pharmaceuticals, textiles, and personal care. With growing concerns about sustainability, efficiency, and safety, catalase is emerging as a vital biocatalyst
Quillaia Extract market is set to reach USD 1,826.9M by 2035 at 5.8% CAGR fueled by natural, functional, and sustainable trends.
Quillaia Extract market is set to reach USD 1,826.9M by 2035 at 5.8% CAGR fueled …
The global Quillaia extract market is entering a period of unprecedented growth, reflecting the world's shift toward natural, functional, and nutrient-rich ingredients. Projected to increase from USD 1,039.6 million in 2025 to USD 1,826.9 million by 2035 at a robust 5.8% CAGR, the industry's future is shaped by consumer demand for healthier, eco-friendly products and manufacturers' determination to stay ahead through innovation, expansion, and diversification. Over the past few years, Quillaia

All 5 Releases


More Releases for Biomarker

Transformative Trends Impacting the Multiplex Biomarker Imaging Market Landscape …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Multiplex Biomarker Imaging Market Size By 2025? In recent times, the size of the multiplex biomarker imaging market has experienced significant growth. There is an expected rise from $0.49 billion in 2024 to $0.54 billion in 2025, with a compound annual growth rate (CAGR) of
Blood-Based Biomarker Market Beyond the Needle: The Future of Diagnostics Lies i …
Blood-Based Biomarker Market worth $51.71 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Blood-Based Biomarker Market - (By Type (Screening Biomarker, Diagnosis Biomarker, Others), By Disease (Cancer, Neurological Disorders, Others), By Application (Diagnostics, Drug Discovery, Personalized Medicine)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic,
Biomarker Discovery Outsourcing Services Market Biomarker Discovery Outsourcing: …
Biomarker Discovery Outsourcing Services Market to reach over USD 52.82 billion by the year 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biomarker Discovery Outsourcing Services Market Size, Share & Trends Analysis Report By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers And Surrogate Endpoints), Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases), Discovery Phase (Biomarker Identification, Biomarker Validation,
Biomarker and Companion Diagnostics Conference | Modeling Strategies for Biomark …
MarketsandMarkets presents the Immunobio Series, an extraordinary set of conferences taking place on 20-21 June 2024 in Boston, USA. Register Now @ https://events.marketsandmarkets.com/2nd-annual-biomarker-and-companion-diagnostics-conference-usa-edition/register MarketsandMarkets 5th Annual Biomarker and Companion Diagnostics Conference: Immerse yourself in the realm of biomarkers at our flagship event, where industry leaders and experts converge to propel innovation in healthcare, diagnostics, and personalized medicine. This conference serves as a dynamic platform for collaboration, knowledge sharing, and exploration of cutting-edge
Central Nervous System (CNS) Biomarkers Market Analysis Forecast 2023-2028 Globa …
The Central Nervous System (CNS) biomarkers market refers to the market for biomarkers used in the diagnosis, prognosis, and monitoring of diseases and disorders affecting the central nervous system. The central nervous system includes the brain and spinal cord, and disorders affecting this system can have significant impacts on an individual's health and well-being. CNS biomarkers are measurable indicators that can provide information about the state of the central nervous system,
Multiplex Biomarker Imaging Market - Advanced Solutions for Comprehensive Biomar …
Newark, New Castle, USA: The "Multiplex Biomarker Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Multiplex Biomarker Imaging Market: https://www.growthplusreports.com/report/multiplex-biomarker-imaging-market/8558 This latest report researches the industry structure,